COVID-19 Treatments: Then and Now
Allergy and Immunology
The Journal of Allergy and Clinical Immunology. In Practice
The coronavirus disease 2019 (COVID-19) pandemic has evolved over the past 3+ years, and strategies to prevent illness and treat infection have changed over time. As COVID-19 transitions from a pandemic to an endemic infection, widespread nonpharmaceutical interventions such as mask mandates and governmental policies requiring social distancing have given way to more selective strategies for risk mitigation. Monoclonal antibody therapies used for disease prevention and treatment lost utility owing to the emergence of resistant viral variants. Oral antiviral medications have become the mainstay of treatment in nonhospitalized individuals, whereas systemic corticosteroids remain the cornerstone of therapy in those requiring supplemental oxygen. Emerging literature also supports the use of additional immune-modulating therapies in select admitted patients. Importantly, the COVID-19 pandemic highlighted both unprecedented research and development of medical interventions while also drawing attention to significant pitfalls in the global response. This review provides a comprehensive update in prevention and management of COVID-19.
Mustafa, S. S., Stern, R. A., Patel, P. C., & Chu, D. K. (2023). COVID-19 Treatments: Then and Now. The Journal of Allergy and Clinical Immunology. In Practice, 11 (11), 3321-3333. https://doi.org/10.1016/j.jaip.2023.07.045